Related Experiment Video
Updated: Jun 21, 2026
08:27
Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes
Published on: March 3, 2023
Metabonomics--a new approach in ophthalmology
1Department of Ophthalmology, Faculty of Medicine, Institute of Neuroscience, Norwegian University of Science and Technology and University Hospital, Trondheim, Norway. anna.midelfart@medicine.ntnu.no
Acta Ophthalmologica
|July 17, 2009
Summary
Metabonomics, using Nuclear Magnetic Resonance (NMR) spectroscopy, offers insights into dynamic metabolic changes. This technology holds promise for advancing eye research and clinical practice by analyzing metabolic profiles.
Area of Science:
- Biochemistry
- Spectroscopy
- Medical research
Background:
- Metabonomics provides comprehensive data on metabolic responses to stimuli.
- Nuclear Magnetic Resonance (NMR) spectroscopy is a key technique for metabolic profiling.
- Current applications of metabonomics in ophthalmology are limited.
Purpose of the Study:
- To introduce the utility of metabonomics in biological research.
- To explore the potential applications of NMR-based metabonomics in eye research.
- To discuss the relevance for clinical practice in ophthalmology.
Main Methods:
- Utilizing Nuclear Magnetic Resonance (NMR) spectroscopy.
- Establishing metabolic profiles of biofluids.
- Examining intact tissue samples.
Main Results:
- NMR spectroscopy enables detailed analysis of metabolic profiles.
- Metabonomics can reveal dynamic metabolic responses in vivo.
- The potential for in vivo eye metabolic analysis is highlighted.
Conclusions:
- Metabonomics is a powerful tool for understanding biological systems.
- NMR-based metabonomics offers novel avenues for eye research.
- This approach may enhance clinical diagnostics and treatment strategies in ophthalmology.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:22Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...